Key facts
- This page summarizes David van Avermaete's Form 4 filing for NeuroMetrix, Inc. (NURO).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 24 May 2024, 17:13.
David van Avermaete - 22 May 2024 Form 4 Insider Report for NeuroMetrix, Inc. (NURO)
- Reporting relationship
- Director
- Issuer ticker
- NURO
- Reported as of
- 22 May 2024
- Net transaction value
- +$60,000
- SEC form
- 4
- Accepted by SEC
- 24 May 2024, 17:13:31 UTC
- Prior SEC filing
- 02 May 2024
- Next SEC filing
- 05 May 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Thomas T. Higgins, Attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
David van Avermaete filed Form 4 for NeuroMetrix, Inc. (NURO) on 24 May 2024.
Change
- Previous filing in this sequence was filed on 02 May 2024.
- Current net transaction value: +$60,000.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
NURO
transaction
Derivative
Restricted Stock Unit
Award
- Transaction value
- $60,000
- Shares
- +13,730
- Change %
- Price
- $4.37
- Shares after
- 13,730
- Date
- 22 May 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 13,730
- Exercise price
- $4.37
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
On May 22, 2024, the reporting person was granted 13,730 restricted stock units with 100% vesting to occur on the earlier of the date of the 2025 annual meeting of stockholders or a change in control of the Issuer, subject to the Reporting Person's continued service on the Board of Directors on such date.
Footnote F2
Pricing on the Nasdaq market on April 30, 2024.